Davidson NE - Search Results

1

Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831.

Moreno-Aspitia A, Hillman DW, Dyar SH, Tenner KS, Gralow J, Kaufman PA, Davidson NE, Lafky JM, Reinholz MM, Lingle WL, Kutteh LA, Carney WP, Dueck AC, Perez EA. Moreno-Aspitia A, et al. Among authors: davidson ne. Cancer. 2013 Aug 1;119(15):2675-82. doi: 10.1002/cncr.28130. Epub 2013 Jun 6. Cancer. 2013. PMID: 23744760 Free PMC article. Clinical Trial.

2

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer.

Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE. Kennedy MJ, et al. Among authors: davidson ne. J Natl Cancer Inst. 1991 Jul 3;83(13):920-6. doi: 10.1093/jnci/83.13.920. J Natl Cancer Inst. 1991. PMID: 1906111 Clinical Trial.

3

Sixteen-week dose-intense chemotherapy in the adjuvant treatment of breast cancer.

Abeloff MD, Beveridge RA, Donehower RC, Fetting JH, Davidson NE, Gordon GG, Waterfield WC, Damron DJ. Abeloff MD, et al. Among authors: davidson ne. J Natl Cancer Inst. 1990 Apr 4;82(7):570-4. doi: 10.1093/jnci/82.7.570. J Natl Cancer Inst. 1990. PMID: 2313733

4

Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy.

Geller RB, Boone LB, Karp JE, Davidson N, Selonick SE, Edwards J, Burke PJ. Geller RB, et al. Cancer. 1989 Aug 1;64(3):629-34. doi: 10.1002/1097-0142(19890801)64:3<629::aid-cncr2820640311>3.0.co;2-l. Cancer. 1989. PMID: 2743258

5

Ovarian ablation as treatment for young women with breast cancer.

Davidson NE. Davidson NE. J Natl Cancer Inst Monogr. 1994;(16):95-9. J Natl Cancer Inst Monogr. 1994. PMID: 7528032 Review.

6

Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells.

Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y, Buckley JA, Isaacs JT, Davidson NE. Armstrong DK, et al. Among authors: davidson ne. Cancer Res. 1994 Oct 15;54(20):5280-3. Cancer Res. 1994. PMID: 7923154

7

Sixteen week dose intense chemotherapy for inoperable, locally advanced breast cancer.

Armstrong DK, Fetting JH, Davidson NE, Gordon GB, Huelskamp AM, Abeloff MD. Armstrong DK, et al. Among authors: davidson ne. Breast Cancer Res Treat. 1993 Dec;28(3):277-84. doi: 10.1007/BF00666589. Breast Cancer Res Treat. 1993. PMID: 8018956 Clinical Trial.

8

Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinoma.

Mikhak B, Zahurak M, Abeloff MD, Fetting JH, Davidson NE, Donehower RC, Waterfield W, Kennedy MJ. Mikhak B, et al. Among authors: davidson ne. Cancer. 1999 Feb 15;85(4):899-904. Cancer. 1999. PMID: 10091768 Clinical Trial.

9

A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.

Subramanyan S, Abeloff MD, Bond SE, Davidson NE, Fetting JH, Gordon GB, Kennedy MJ. Subramanyan S, et al. Among authors: davidson ne. Cancer Chemother Pharmacol. 1999;43(6):497-502. doi: 10.1007/s002800050929. Cancer Chemother Pharmacol. 1999. PMID: 10321510 Clinical Trial.

10

Ovarian ablation as adjuvant therapy for breast cancer.

Dees EC, Davidson NE. Dees EC, et al. Among authors: davidson ne. Semin Oncol. 2001 Aug;28(4):322-31. doi: 10.1016/s0093-7754(01)90126-5. Semin Oncol. 2001. PMID: 11498826 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

410 results

Search Page

Filters